ABSTRACT
Introduction
Autosomal polycystic kidney disease (ADPKD) has a hereditary transmission and affects almost 12.5 million people worldwide, with an european prevalence less than 5 patients to 10000 people, and about 4000 cases in Romania (1) . This disorder is caused by mutations in either of two genes: PKD-1 (polycystin-1) on chromosome 16, or PKD-2 (polycystin-2) on chromosome 4, and have various extrarenal manifestation as: hepatic cysts, intracranial aneurysms and arterial hypertension (2, 3) . Hypertension occurs early in ADPKD, usually before renal failure. Up regulation of the renin-1 Faculty of Medicine, University "Ovidius" of Constanța angiotensin-aldosteron system is the major key in pathogenesis of hypertension, possibly caused by renal vascular compression due to cyst expansion (4, 5) . However, association with hypokalemia is very rare in these patients and is necessary to exclude other causes.
We report the case of a 45-year-old man hospitalized in Nephrology Department of Emergency County Hospital Constanta for severe sinus bradycardia ( Figure 1) Checking the previous laboratory test we found a moderate hypokalemia one year before, with serum potassium level 2.4 mmol/L.
Abdominal computer tomography (CT) ( Figure 2 ) revealed a hypodense tumor in the left adrenal gland of 27/12 mm ( Figure 1) . A low plasma renin activity determined by chemiluminescence techniques (2.2 ng/mL/h) with normal salt diet for 5 days was found. A spot of urine potassium level was 11 mEq/L and the aldosterone serum level was 145.3ng/dL (normal range between 1.76-23.2 ng/dL 
. Abdominal CT scan showing multiple hepatorenal cysts (A) and macroadenoma in left adrenal gland (B)
After treatment with iv potassium chloride, kalemia progressively increased (initial 60 ml/ day, then 120 ml/day) and, associated with antialdosteronic diuretic (spironolactone 150 mg/ day) and oral potassium supplements, the serum potassium level reached normal value (Table 1) . The surgical excision of the adenoma was considered but it was excluded due to the extremely difficult surgical approach. However, the serum potassium level was maintained within normal values only with anti-aldosterone treatment (spironolactone) at the dose of 100 mg/ day.
Tabel 1. Serum Potassium level evolution after treatment

Discussion
Primary hyperaldosteronism (PA) occurs as a result of autonomous hypersecretion of aldosterone with suppressed serum renin level being responsible of 5% to 12% of all secondary hypertension (6-8), 8 .75% reported in a romanian study (9) . Most frequent etiology is unilateral or bilateral adrenal tumor and the hallmark of the disease is hypokalemia resulting from persistent potassium secretion mediated by aldosterone activity in the renal collecting tubule. Positive screening for primary hyperaldosteronism is ratio of aldosterone plasma concentration (ng/dL)/ direct renin plasma concentration (ng/L) higher than 7.7 or ratio between aldosterone plasma concentration (ng/dL) and plasma renin activity (ng/mL/h) over 40.
However, hypokalemia occurs rarely also in ADPKD making differential diagnosis more difficult. By now, a total of 13 patients (3 men and 10 women) with ADPKD associated with Conn disease (primary aldosteronism) have been reported in the literature (10) (11) (12) (13) (14) (15) . The mean age at diagnosis of primary aldosteronism was 40 years old ( age range between 23 to 57 years) and all the patients presented plasma hypokalemia (mean K= 2.6 ± 0.8 mEq/L) and low plasma renin activity (average of 0.31 ± 0.22 ng/mL/h) at the time of diagnosis. Only in 4 cases antialdosterone medication was administered, in all the other patients adrenalectomy was performed.
Some studies have shown that persistent hypokalemia has a role in kidney cysts formation in patients with PA and ADPKD (16, 17) and may lead to kidney failure. In addition to worsening of hypertension, hyperaldosteronism may contribute to the increase in size of renal cysts and the appearance of renal fibrosis due to the occurrence of inflammatory processes in the target organs. In addition to the vascular effect due to renin angiotensin aldosterone system (RAAS) activity, aldosterone excess contributes to the development of metabolic syndrome associated with hypertension, endothelial dysfunction and insulin resistance (18) .
On the other hand, hypertension in patients with ADPKD occurs mainly as a result of RAAS activation, possibly by compression of the renal vascular system as a result of the enlargement of the cyst, leading to bilateral renal ischemia. In some studies, it was observed that plasma renin activity and aldosterone plasma concentration in hypertensive patients with ADPKD were significantly higher than in patients with essential hypertension (19) . Other studies support the major role of intrarenal RAAS activity in the occurrence of secondary hypertension in patients with ADPKD. Activation of RAAS may increase the formation and augmentation of the renal cysts through its mitogenic effects (20) . The other causes involved in the pathogenesis of hypertension in ADPKD are increased sympathetic nervous system activity and arterial stiffness endothelial dysfunction, increased endothelin-1 secretion.
Also, there are reported 3 cases of hypokalemia associated with hypertension due to secondary hyperaldosteronism in patient with ADPKD (21) (22) (23) . Therefore, imaging by abdominal CT or MRI, are recommended for the correct diagnosis.
The sensitivity of CT imaging to differentiate solitary adenoma from adrenal hyperplasia has been reported at 85% (24) or higher (25) . In our case, the abdominal CT scan showed a well-defined hypodense mass in the left adrenal gland and normal aspect of the right (Figure 1) .
The particularity of our case is the presence of liver cysts and the history of repeated cerebral hemorrhage, as a result of cerebral aneurysmal dilatations. Also, the initial value of serum potassium was lower compared to the reported cases. Low plasma renin activity and abdominal computer tomography have established the diagnosis. After literature review, it seems to be the second reported case of PA-associated with autosomal dominant polycystic kidney and liver disease, but the first with other complications of ADPKD, such as cerebral aneurysmal dilatation.
Renal cysts also have been reported to develop in patients with primary or secondary hyperaldosteronism where hypokalemia was present. Although these studies do not demonstrate causality, the relationship between PA and ADPKD requires further investigation. After treatment of PA and normalization of potassium levels it is necessary to monitoring the change in cyst size and number. The cyst evolution may help explain the interaction between PA and ADPKD; in addition, further studies are needed to determine whether adrenalectomy may lead to worsening of renal function and progression of ADPKD.
Conclusion
In ADPKD patients associated with resistant hypertension and hypokalemia, other cause of hypertension should be considered, like primary aldosteronism.
